Stockreport

Sonnet BioTherapeutics Announces Review of Strategic Alternatives [Yahoo! Finance]

Sonnet BioTherapeutics Holdings, Inc.  (SONN) 
PDF developing targeted immunotherapeutic drugs, announced today that its Board of Directors has initiated a process to explore and review a range of strategic alternatives [Read more]